|
AGL expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.40439939864268E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.5326000185899E-09 |
| Normal-vs-Stage2 |
6.231200E-04 |
| Normal-vs-Stage3 |
8.32590000054978E-07 |
| Normal-vs-Stage4 |
1.69130000005069E-06 |
| Stage1-vs-Stage2 |
9.961400E-01 |
| Stage1-vs-Stage3 |
3.918800E-01 |
| Stage1-vs-Stage4 |
4.676800E-01 |
| Stage2-vs-Stage3 |
4.709800E-01 |
| Stage2-vs-Stage4 |
4.478200E-01 |
| Stage3-vs-Stage4 |
8.442600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.7275961751202E-11 |
| Normal-vs-AfricanAmerican |
2.44329999998794E-06 |
| Normal-vs-Asian |
7.69310000000578E-05 |
| Caucasian-vs-AfricanAmerican |
7.181400E-01 |
| Caucasian-vs-Asian |
5.988600E-01 |
| AfricanAmerican-vs-Asian |
5.743200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.4806827399243E-12 |
| Normal-vs-Female |
1.218990E-04 |
| Male-vs-Female |
4.914000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.32859999966296E-07 |
| Normal-vs-Extreme_Weight |
1.29279920102476E-11 |
| Normal-vs-Obese |
3.29989999769964E-08 |
| Normal-vs-Extreme_Obese |
5.326000E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.367800E-01 |
| Normal_Weight-vs-Obese |
7.226600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.413200E-01 |
| Extreme_Weight-vs-Obese |
3.188400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.821590E-01 |
| Obese-vs-Extreme_Obese |
2.850400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.46850000048993E-07 |
| Normal-vs-Age(41-60Yrs) |
4.27860002982783E-09 |
| Normal-vs-Age(61-80Yrs) |
5.57920043497973E-10 |
| Normal-vs-Age(81-100Yrs) |
1.00069999997565E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.847400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.755600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.099800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.279600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.558000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.719800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.80650005644179E-11 |
| Normal-VS-Type2 PRCC |
1.41959999999663E-06 |
| Normal-VS-KIRP CIMP |
1.74630000460141E-08 |
| Normal-VS-Unclassified PRCC |
1.215960E-03 |
| Type1 PRCC-VS-Type2 PRCC |
9.344600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.338990E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.633000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.428300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.732600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.545800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.43160003243759E-09 |
| Normal-vs-N1 |
2.12640000052389E-07 |
| Normal-vs-N2 |
1.63827999999366E-05 |
| N0-vs-N1 |
4.992000E-01 |
| N0-vs-N2 |
3.299000E-01 |
| N1-vs-N2 |
4.936200E-01 |
|
|
